ATC level 2
J04Tuberculosis and leprosy medicines
- Molecules
- 12
- Subgroups
- 2
ATC J04 (Tuberculosis and leprosy medicines) is a level 2 group in the anatomical therapeutic chemical classification. The catalogue lists 12 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under J04.
- BedaquilineOrphanDiarylquinoline Antimycobacterial2 presentations1 brandJ04AK05
- ClofazimineOrphanAntimycobacterial1 presentation1 brandJ04BA01
- Cycloserine1 presentationJ04AB01
- DapsoneSulfone5 presentations1 brandD10AX05
- Delamanid1 brandJ04AK06
- EthambutolAntimycobacterial2 presentationsJ04AK02
- IsoniazidAntimycobacterial4 presentationsJ04AC01
- PretomanidOrphanAntimycobacterial1 presentation1 brandJ04
- PyrazinamideAntimycobacterial1 presentationJ04AK01
- RifabutinOrphanRifamycin Antimycobacterial1 presentationJ04AB04
- RifampinOrphanRifamycin Antibacterial4 presentationsJ04AB02
- RifapentineOrphanRifamycin Antimycobacterial2 presentations1 brandJ04AB05
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.